Author:
Değerli Elif,Torun Vildan,Cansaran-Duman Demet
Abstract
Abstract
Background
Breast cancer is the most common cancer types among women. Recent researches have focused on determining the efficiency of alternative molecules and miRNAs in breast cancer treatment. The aim of this study was to determine the effect of usnic acid response-miR-185-5p on proliferation in the breast cancer cell and to determine its relationship with apoptosis pathway.
Methods
The cell proliferation and cell apoptosis rate were significantly increased following the ectopic expression of miR-185-5p in BT-474 cells. Furthermore, the results of cell cycle assay performed by flow cytometry revealed that the transfection with miR-185-5p induced G1/S phase arrest. The apoptosis-related genes expression analysis was performed by qRT-PCR and the direct target of miR-185-5p in BT-474 cells was identified by western blot and luciferase reporter assay.
Results
Our data showed that miR-185-5p can cause significant changes in apoptosis-related genes expression levels, suggesting that cell proliferation was suppressed by miR-185-5p via inducing apoptosis in breast cancer cells. According to western blot results, miR-185-5p lead to decrease BCL2 protein level in BT-474 cells and direct target of miR-185-5p was identified as BCL by luciferase reporter assay.
Conclusion
This study revealed that miR-185-5p may be an effective agent in the treatment of breast cancer.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Gates R, Regina M. Oncology nursing secrets. 3rd ed. Amsterdam: Elsevier; 2008.
2. Gong Y, He T, Yang L, Yang G, Chen Y, Zhang X. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci Rep. 2015;5:1–13.
3. Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-B-inducing kinase (NIK). Oncogene. 2012;31(31):3607–20.
4. Rogers Seton S. Chemotherapy: preventing competitive release. Nat Rev Cancer. 2016;16(4):199.
5. Plantamura I, Cosentino G, Cataldo A. MicroRNAs and DNA-damaging drugs in breast cancer: strength in numbers. Front Oncol. 2018;8(September):1–10.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献